March 4

Biomedical technology putting the patient in the driver’s seat

Robin Farmanfarmaian is an expert at being a patient. Misdiagnosed at the age of 16 with an autoimmune disease, Farmanfarmaian has had 43 hospitalizations and six major surgeries. At 26, when ... > MORE

2019 AAD president-elect address: My three greatest lessons

There’s joy in practicing dermatology. That’s the heartfelt expression George Hruza, MD, MBA, conveyed during his 2019 American Academy of Dermatology president-elect address. Dr. Hruza attributed his ... > MORE

AAD President Suzanne Olbricht, MD, encourages a future for all

Serving as AAD President marks a year of achievements and pride for Suzanne Olbricht, MD, but it takes a back seat to her real passion — everyday patient care. On Sunday, Dr. Olbricht delivered the ... > MORE

Derm on the Street

Dermatology World Election Correspondent Terry Cronin Jr., MD, asked dermatologists at the Annual Meeting what their top issues in this year’s election are. Derm on the Street ... > MORE

The search for the next “isotretinoin”

When presenting the Marion B. Sulzberger, MD Memorial Award and Lectureship on Sunday, Diane Thiboutot, MD, recognized Dr. Sulzberger’s strong influence in allergy, immunology, and dermatology, ... > MORE

New treatment for Merkel cell carcinoma “less toxic, more effective”

Paul Nghiem, MD, PhD, has spent the past 15 years working to lead a multidisciplinary research strategy to better understand and treat Merkel cell carcinoma (MCC), a rare skin cancer that is ... > MORE

Lushniak: Dermatologists can change the world. Joyfully

Service is about expanding what you think you are, what you think you can do, what you think you can accomplish. “When you think about yourself, skip the ‘only,’ as in ‘I’m only a surgeon’ or ... > MORE

Engineered T cells provide more opportunities for cancer therapy

Immunotherapy is “a revolution in cancer therapy,” according to Crystal L. Mackall, MD, director of the Stanford Center for Cancer Cell Therapy and the Parker Institute for Cancer Immunotherapy at ... > MORE